A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Cited by (999)

Items 801–900 of 999

1. Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
   Simone P. Rauh, Femke Rutters, Brian Larsen Thorsted, Michael Lyng Wolden, Giel Nijpels, Amber A. W. A. van der Heijden, Iris Walraven, Petra J. M. Elders, Martijn W. Heymans, Jacqueline M Dekker · 2016 · BMJ Open
2. Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome
   Barbara Elisabeth Stähli, Anna Nozza, Ilse C. Schrieks, John B. Buse, Klas Malmberg, Linda Mellbin, Bruce Charles Neal, Stephen James Nicholls, Lars Rydén, Anders Svensson et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
3. Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery disease
   Safi Ullah Khan, Maninder Singh, Ahmad Naeem Lone, Muhammad Shahzeb Khan, Urooj Fatima, Abu Bakar Ali Saad, Haris Riaz, Isaac Opoku-Asare, Edo Kaluski · 2018 · European Journal of Preventive Cardiology
4. Invasive Management of Coronary Artery Disease in Advanced Renal Disease
   Keyvan Karimi Galougahi, Steven James Chadban, Roxana Mehran, Sripal Bangalore, Glenn Matthew Chertow, Ziad A. Ali · 2021 · Kidney International Reports
5. Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
   Yang, Ye, Kenneth B. Pomerantz, Murray W Stewart · 2013 · Diabetes Metabolic Syndrome and Obesity
6. Clinical practice and implications of recent diabetes trials
   Mark W.I. Webster · 2011 · Current Opinion in Cardiology
7. Insulin resistance and cardiovascular outcomes in the ORIGIN trial
   Hertzel C. Gerstein, Ele Ferrannini, Matthew C. Riddle, Salim Yusuf, ORIGIN Trial Investigators · 2017 · Diabetes Obesity and Metabolism
8. The Need for Sex-Specific Data Prior to Food and Drug Adminstration Approval
   Sanket Shishir Dhruva, Rita F. Redberg · 2010 · Journal of the American College of Cardiology
9. CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?∗
   William E. Boden, G.B. John Mancini · 2016 · Journal of the American College of Cardiology
10. Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
    Tobias Michiel Hommels, Renicus Suffridus Hermanides, Enrico Fabris, Elvin Kedhi · 2023 · Cardiovascular Diabetology
11. An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease
    Lei Bi, Yu Geng, Yintang Wang, Siyuan Li, Kuogen Sun, Yiqi Guo, Ou Zhang, Ping Zhang · 2024 · BMC Cardiovascular Disorders
12. Thirty-Year Trends in Outcomes of Percutaneous Coronary Interventions in Diabetic Patients
    Mandeep Singh, David R. Holmes, Bernard John Gersh, Robert L. Frye, Ryan J. Lennon, Charanjit S. Rihal · 2012 · Mayo Clinic Proceedings
13. Prognostic relevance of PCI-related myocardial infarction
    Pier Woudstra, Maik J. Grundeken, Tim P. van de Hoef, Lars C. Wallentin, Keith A.A. Fox, Robbert J. de Winter, Peter Damman · 2013 · Nature Reviews Cardiology
14. Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight
    Reilly W. Coch, J.B. Green · 2016 · Nutrition Metabolism and Cardiovascular Diseases
15. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia
    Kevin R. Bainey, Jerome L. Fleg, Judith S. Hochman, Dennis F. Kunichoff, Rebecca Anthopolos, Alexander M. Chernyavskiy, Marcin Demkow, Juan Manuel López-Quijano, Jorge Escobedo, Kian Keong Poh et al. · 2021 · American Heart Journal
16. Kommentar zu den 2013 Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management der stabilen koronaren Herzkrankheit (KHK)
    Udo P Sechtem, Stephan S. Achenbach, Anselm Kai Gitt, N. Marx, Malte Kelm, Volker Schächinger · 2015 · Der Kardiologe
17. Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?
    Pahul Preet Singh, Nishant Sethi, Navneet Kaur, Hani Kozman · 2015 · Clinical Medicine Insights Cardiology
18. Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: From BARI to SYNTAX
    George N. Hahalis, George Dangas, Periklis A. Davlouros, Dimitrios K. Alexopoulos · 2011 · International Journal of Cardiology
19. Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics
    Daniel B. Larach, Marina Cuchel, Daniel James Rader · 2013 · Clinical Lipidology
20. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention
    Amer Kasim Ardati, Bertram Pitt, Dean E. Smith, Herbert D. Aronow, David A. Share, Mauro M. Moscucci, Stanley J. Chetcuti, Paul Michael Grossman, Hitinder Singh Gurm · 2013 · American Heart Journal
21. Impact of Diabetes Among Revascularized Patients in Japan and the U.S.
    Shun Kohsaka, Masashi Goto, Toshiyuki Nagai, Vei‐Vei Lee, MacArthur A. Elayda, Yutaka Furukawa, Masanori Fukushima, Masashi Komeda, Ryuzo Sakata, Mitsuru Ohsugi et al. · 2012 · Diabetes Care
22. Vascular repair strategies in type 2 diabetes: novel insights.
    Kira Kuschnerus, Ulf Landmesser, Nicolle Kränkel · 2015 · PubMed Central
23. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score
    Anna Oleksiak, Mariusz B.P. Kruk, Ewelina Lenarczyk, Magdalena M. Pawelec, Ewa Rajska, Paulina Wilkońska, Zofia Dzielińska, Marcin Demkow, Adam Witkowski, Jerzy Pręgowski et al. · 2015 · Atherosclerosis
24. HbA1c Levels and Long-Term Mortality in Patients Undergoing Coronary Angiography
    Ofer Havakuk, Shmuel Banai, Amir Halkin, Maayan Konigstein, Eyal Ben–Assa, Shlomo A. Berliner, Tomer Ziv‐Baran, Meital Elbaz, Miri Revivo, Gad Keren et al. · 2016 · Cardiology
25. Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result
    Karl Isaaz, Antoine Gerbay, Jérémy Terreaux, Hazem Khamis, Khalid Omar Tammam, L Richard, Alexis Cerisier, Michel Lamaud, Antoine Da Costa · 2016 · International Journal of Cardiology
26. Coronary Physiology Assessment for the Diagnosis and Treatment of Stable Ischemic Heart Disease
    Ali Emin Denktas, David E. Paniagua, Hani M. Jneid · 2016 · Current Atherosclerosis Reports
27. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme — A tertiary centre experience from Western India
    Devendra Patil, Charan Pandurang Lanjewar, Goutam Vaggar, Juhi Bhargava, Girish Ramkrishna Sabnis, Jivtesh S. Pahwa, Ankur Phatarpekar, Hetan Chandrakant Shah, Prafulla Gopinath Kerkar · 2017 · Indian Heart Journal
28. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes
    Ayesha Siddique, Timothy P. Murphy, Syed Saad Naeem, Efaza Umar Siddiqui, Karol Mateusz Pencina, Gregory E. McEnteggart, Frank William Sellke, Lance D. Dworkin · 2018 · Catheterization and Cardiovascular Interventions
29. Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes
    Leslee J. Shaw, Ron Blankstein, David Brown, Sanket Shishir Dhruva, Pamela S. Douglas, Tessa S.S. Genders, Raymond J. Gibbons, John Pierre Greenwood, Raymond Y.K. Kwong, Jonathon A Leipsic et al. · 2019 · JACC. Cardiovascular imaging
30. Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Patients with Diabetic Nephropathy and Left Main Coronary Artery Disease.
    Hsin Ru Li, Chiao Po Hsu, Shih‐Hsien Sung, Chun Che Shih, Shing Jong Lin, Wan‐Leong Chan, Cheng Wu, Tse‐Min Lu · 2017 · PubMed Central
31. Innovation in medical imaging to improve disease staging, therapeutic intervention, and clinical outcomes
    Marwa Daghem, David Ernest Newby · 2020 · Atherosclerosis
32. Hypoglycemia-induced changes in complement pathways in type 2 diabetes
    Abu Saleh Md Moin, Manjula Nandakumar, Ilhame Diboun, Ahmed Al‐Qaissi, Thozhukat Sathyapalan, Stephen Lawrence Atkin, Alexandra E. Butler · 2021 · Atherosclerosis Plus
33. Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
    Chih‐Neng Hsu, Chin‐Feng Hsuan, Daniel Liao, Jack. Keng-Jui Chang, Allen Jiun-Wei Chang, Siow‐Wey Hee, Hsiao-Lin Lee, Sean I. F. Teng · 2023 · Life
34. Predictors and Outcomes of Routine Versus Optimal Medical Therapy in Stable Coronary Heart Disease
    Soohun Chun, Feng Qiu, Peter C. Austin, Dennis T. Ko, Muhammad Mamdani, Duminda Nalaka Wijeysundera, Andrew Czarnecki, Maria C. Bennell, Harindra Channa Wijeysundera · 2015 · The American Journal of Cardiology
35. Cardiovascular risk stratification in diabetic patients
    Mario Petretta, Wanda Acampa, Giovanni Fiumara, Alberto Cuocolo · 2013 · Clinical and Translational Imaging
36. Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting
    Matteo Anselmino, Klas Malmberg, Linda Mellbin, Lars Rydén · 2010 · Reviews in Endocrine and Metabolic Disorders
37. Alternative Strategies for the Management of Chronic Stable Angina
    Robert A. O’Rourke · 2010 · Current Problems in Cardiology
38. Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients
    Young‐Hak Kim, Duk‐Woo Park, Jung‐Min Ahn, Gyung‐Min Park, Yong-Rak Cho, Jong‐Young Lee, Won-Jang Kim, Sung‐Cheol Yun, Soo‐Jin Kang, Seung‐Whan Lee et al. · 2013 · EuroIntervention
39. Fractional flow reserve computed tomography in the evaluation of coronary artery disease
    Shaw Hua Kueh, Matthew Boroditsky, Jonathon A Leipsic · 2017 · Cardiovascular Diagnosis and Therapy
40. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
    Victoria McCreanor, Nicholas Graves, Adrian Gerard Barnett, William Anthony Parsonage, Gregory Merlo · 2018 · F1000Research
41. Glucose-lowering treatment in cardiovascular and peripheral artery disease
    Rosa Suades, Francesco Cosentino, Lina Badimón · 2018 · Current Opinion in Pharmacology
42. Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling
    Oronzo Catalano, Guido Moro, Alessia Mori, Mariarosa Perotti, Alessandra Gualco, Mauro Frascaroli, Clara Pesarin, Carlo Napolitano, Ntobeko Ntusi, Silvia Giuliana Priori · 2018 · BioMed Research International
43. Diabetes and multivessel disease
    Lucas C. Godoy, Vivek A. Rao, Michael E. Farkouh · 2018 · Current Opinion in Cardiology
44. Modelling of the ICF core sets for chronic ischemic heart disease using the LASSO model in Chinese patients
    Meng You, Wen Fang, Xu Wang, Tiantong Yang · 2018 · Health and Quality of Life Outcomes
45. Chronic Heart Failure and Diabetes Mellitus: Pathogenesis and Possibilities of Treatment
    А. Г. Обрезан, Н. В. Куликов · 2018 · Kardiologiia
46. Screening asymptomatic patients with diabetes for unknown coronary artery disease: Does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D Trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?)
    Fabrizio Turrini, R Messora, Paolo Giovanardi, Stefano Tondi, Paolo Magnavacchi, Rita Cavani, Giandomenico Tosoni, Carlo Cappelli, Elisa Pellegrini, Stefania Romano et al. · 2009 · Trials
47. Coronary Artery Revascularization in Chronic Kidney Disease
    Usman Baber, Roxana Mehran · 2015 · Circulation Cardiovascular Interventions
48. Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
    Fuentes, B., Amaro, S., Alonso de Leciñana, M., Arenillas, J.F., Ayo-Martín, O., Castellanos, M., Freijo, M., García-Pastor, A., Gomis, M., Gómez Choco, M. et al. · 2021 · Neurología
49. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco, Grant, Peter J, Aboyans, Victor, Bailey, Clifford J, Ceriello, Antonio, Delgado, Victoria, Federici, Massimo, Filippatos, Gerasimos, Grobbee, Diederick E, Hansen, Tina Birgitte et al. · 2020 · European Heart Journal
50. The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review
    Daniel S. Hirsch, Brandon Lau, Virag V. Kushwaha, Kenneth Yong · 2023 · Reviews in Cardiovascular Medicine
51. Imaging approaches in risk stratification of patients with coronary artery disease: a narrative review
    Gloria Santangelo, Elisa Gherbesi, Luca Donisi, Andrea Faggiano, Luca Bergamaschi, Carmine Pizzi, Stefano Carugo, Massimiliano Ruscica, Pompilio Massimo Faggiano · 2024 · Archives of Medical Science
52. Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial
    Sripal Bangalore, Grace L. Rhodes, David Joel Maron, Rebecca Anthopolos, Sean M. O’Brien, Philip G. Jones, Daniel B. Mark, Harmony R. Reynolds, John A. Spertus, Gregg W. Stone et al. · 2024 · EuroIntervention
53. Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
    Heejun Son, Suk Ho Sohn, Hyun Ah Kim, Hun Jee Choe, Hyunsuk Lee, Hye Seung Jung, Young Min Cho, Kyong Soo Park, Ho Young Hwang, Soo Heon Kwak · 2025 · Diabetes Obesity and Metabolism
54. Chronic Coronary Artery Disease
    Michelle Maya Kittleson · 2025 · Annals of Internal Medicine
55. What Is Ischemia and How Should This Be Defined Based on Modern Imaging?
    Robert Bober, Eiman Jahangir · 2015 · Progress in Cardiovascular Diseases
56. Influence of Abnormal Fasting Plasma Glucose on Left Ventricular Function in Older Patients With Acute Myocardial Infarction
    Shiwei Yang, Yujie Zhou, Yuyang Liu, Dayi Hu, Yujie Shi, Xiaomin Nie, Fei Gao, Bin Hu, Dean Jia, Zhe Fang et al. · 2011 · Angiology
57. Glycemic Management in Diabetes and the Associated Cardiovascular Risk
    Masaya Koshizaka, Jennifer B. Green, John Hunter Alexander · 2012 · Circulation Journal
58. Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy
    Francesco Nudi, Natale Di Belardino, Francesco Versaci, Annamaria Pinto, Enrica Procaccini, Giandomenico Neri, Maurizio Vetere, Giacomo Frati, Mariangela Peruzzi, Orazio Schillaci et al. · 2016 · Journal of Nuclear Cardiology
59. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)
    Paulo Cury Rezende, Whady Armindo Hueb, Edimar Alcides Bocchi, Michael E. Farkouh, Carlos Vicente Serrano Junior, Eduardo Gomes Lima, Expedito Eustáquio Ribeiro Silva, Luís Alberto Oliveira Dallan, Fábio Antônio Gaiotto, Cibele Larrosa Garzillo et al. · 2020 · Trials
60. Improving the Design of Future PCI Trials for Stable Coronary Artery Disease
    Guillaume Marquis‐Gravel, David J. Moliterno, Dárrel P. Francis, Peter Jüni, Yves Rosenberg, Bimmer E.P.M. Claessen, Robert John Mentz, Roxana Mehran, Donald E. Cutlip, Cynthia Chauhan et al. · 2020 · Journal of the American College of Cardiology
61. Implications of the ISCHEMIA trial on the practice of surgical myocardial revascularization
    Marc Ruel, Louise Y. Sun, Michael E. Farkouh, Mario F.L. Gaudino · 2020 · Journal of Thoracic and Cardiovascular Surgery
62. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics
    Yong‐Giun Kim, Gyung‐Min Park, Seung Bum Lee, Dong Hyun Yang, Joon‐Won Kang, Tae‐Hwan Lim, Hong‐Kyu Kim, Jaewon Choe, Seung‐Whan Lee, Young‐Hak Kim · 2020 · Scientific Reports
63. Nationwide Trends and Outcomes for Coronary Artery Bypass Grafting in End-Stage Kidney Disease and Stable Coronary Artery Disease
    Rhythm Vasudeva, Harsh Mehta, Wan‐Chi Chan, Monil M. Majmundar, Sri G. Yarlagadda, Peter S. Downey, Emmanuel Daon, Greg Muehlebach, Matthew R. Danter, George L. Zorn et al. · 2023 · The American Journal of Cardiology
64. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial
    Robert A. Wolk, Marnie H. Bertolet, Maria M. Brooks, Richard E. Pratley, Burton E. Sobel, Robert L. Frye, Prachi Singh, Andrew D. Calvin, Martin K. Rutter, Arshag D. Mooradian et al. · 2014 · European Journal of Preventive Cardiology
65. An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies
    Cengiz Taşçı, Nihat Özçelik · 2011 · Molecular Imaging and Radionuclide Therapy
66. Benefit of revascularization for stable ischaemic heart disease: the jury is still out
    Amir-Ali Fassa, William C. Wijns, Philippe H. Kolh, Philippe Gabríel Steg · 2013 · European Heart Journal
67. Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus
    Neal B. Patel, Gary John Balady · 2010 · Reviews in Endocrine and Metabolic Disorders
68. What is the role of coronary angioplasty and stenting in stable angina?
    Rasha Kadem Al-Lamee, Justin E. Davies, Iqbal Saeed Malik · 2016 · BMJ
69. Testing in Patients With Stable Coronary Artery Disease – The Debate Continues –
    Udo P Sechtem, Heiko Mahrholdt, Peter Ong, Anastasios Athanasiadis, Tim G. Schäufele · 2016 · Circulation Journal
70. Rationale and design of the Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization: Relation to Cardiovascular Outcomes, Cost Effectiveness and Quality of Life (CONSERVE) trial
    Sang‐Eun Lee, Fay Yu-Huei Lin, Yao Lu, Hyuk‐Jae Chang, James K. Min · 2016 · American Heart Journal
71. The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification
    Asrar Ahmad Khan, Matthew J. Chung, Eric L. Novak, Maria M. Brooks, David Brown · 2017 · European Journal of Preventive Cardiology
72. Coronary Revascularization in the United States—Patient Characteristics and Outcomes in 2020
    Debabrata Mukherjee · 2020 · JAMA Network Open
73. Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes
    Eduardo Flores‐Umanzor, Pedro Luis Cepas Guillén, Sara Vázquez‐Calvo, Andrea Fernández-Valledor, Juan Betuel Ivey-Miranda, Marc Izquierdo, Guillem Caldentey, Gustavo Jiménez-Brítez, Ander Regueiro, Xavier Freixa et al. · 2020 · Catheterization and Cardiovascular Interventions
74. Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study)
    Danai Kitkungvan, Nils P. Johnson, Richard L. Kirkeeide, Mary Haynie, Catharine Carter, Monica Patel, Linh Bui, Mohammad Madjid, Patricia Mendoza, Amanda E. Roby et al. · 2021 · American Heart Journal
75. Cost‐Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program
    Matthew R. Reynolds, Tingting Gong, Shuling Li, Charles A. Herzog, David M. Charytan · 2021 · Journal of the American Heart Association
76. Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions
    Andreas Seraphim, Kristopher D. Knott, João B. Augusto, Katia Menacho, Sara Moiz Tyebally, Benjamin Dowsing, Sanjeev Bhattacharyya, Leon Menezes, Daniel A. Jones, Rakesh Uppal et al. · 2021 · Frontiers in Cardiovascular Medicine
77. Revascularisation for Ischaemic Cardiomyopathy
    Matthew Li Kam Wa, Saba Z Assar, Ajay Jayant Kirtane, Divaka Perera · 2023 · Interventional Cardiology Reviews Research Resources
78. Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes
    Udaya M. Kabadi · 2015 · Journal of Diabetes Mellitus
79. Thiazolidinedione use is not associated with worse cardiovascular outcomes: A study in 28,332 high risk patients with diabetes in routine clinical practice
    Ronan Roussel, Samy Hadjadj, Blandine Pasquet, Peter W.F. Wilson, Sidney C. Smith, Shinya Goto, Florence Tubach, Michel Marre, Avi Porath, Michel Krempf et al. · 2012 · International Journal of Cardiology
80. State of the art papers Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
    Vasilios Gabriel Athyros, Thomas D Gossios, Κωνσταντίνος Τζιόμαλος, Matilda Florentin, Asterios I. Karagiannis, Dimitri P. Mikhailidis · 2011 · Archives of Medical Science
81. Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D)
    Sheng‐Chia Chung, Mark Andrew Hlatky, Roslyn A. Stone, Jamal S. Rana, Jorge Escobedo, William J. Rogers, Joyce T. Bromberger, Sheryl F. Kelsey, Maria M. Brooks · 2011 · American Heart Journal
82. Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification
    Stefano Muzzarelli, Matthias Emil Pfisterer, Jan Müller‐Brand, Michael Johannes Zellweger · 2010 · International journal of cardiac imaging
83. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial
    Burton E. Sobel · 2010 · Coronary Artery Disease
84. Revascularization in Patients with Diabetes: PCI or CABG or None at All
    Kreton Mavromatis, Habib Samady, Spencer B. King · 2015 · Current Cardiology Reports
85. Blood Glucose Control and Coronary Heart Disease
    Cristina Bianchi, Giuseppe Penno, Roberto Miccoli, Stefano Del Prato · 2010 · Herz
86. Non-invasive assessment of coronary artery disease in diabetes
    Nico R. Van de Veire, Roxana Djaberi, Joanne Désirée Schuijf, Jeroen Joost Bax · 2010 · Heart
87. Type 2 diabetes mellitus: Link between diet, HbA1c and complications
    Waqas Sami, Tahir Ansari · 2016 · Australasian Medical Journal
88. Contextualizing Myocardial Infarction: Comorbidities and Priorities in Older Adults
    Ashok Krishnaswami, Mathew S. Maurer, Karen P. Alexander · 2017 · The American Journal of Medicine
89. Ischemic left ventricle systolic dysfunction: An evidence-based approach in diagnostic tools and therapeutics
    Eduardo Gomes Lima, Felipe Pereira Câmara de Carvalho, Jaime Paula Pessoa Linhares Filho, Fabio Grunspun Pitta, Carlos Vicente Serrano Junior · 2017 · Revista da Associação Médica Brasileira
90. Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease
    Martial Hamon, Gilles Lemesle, Thibaud Meurice, Olivier Tricot, Nicolas Lamblin, Christophe Bauters · 2018 · JACC: Cardiovascular Interventions
91. Type 1 diabetes mellitus and coronary revascularization
    Helene Mamet, Mark Colquhoun Petrie, Paul Rocchiccioli · 2019 · Cardiovascular Endocrinology & Metabolism
92. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study
    Adriana Silveira de Almeida, Sandra Cristina Pereira Costa Fuchs, Felipe Costa Fuchs, Aline Gonçalves Silva, Marcelo B. Lucca, Samuel Scopel, Flávio Danni Fuchs · 2020 · Vascular Health and Risk Management
93. Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology?
    Mihaela D. Aldea, Ciprian Tomuleasa, Bobe Petrushev, Sergiu Șușman, G I Kacso, Alexandra Iulia Irimie, Ioan Ştefan Florian, O Soritau · 2011 · PubMed
94. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease
    D P Taggart · 2013 · European Journal of Cardio-Thoracic Surgery
95. How Should We Interpret the Decrease in Annual Volume of Stress Imaging Tests for Evaluation of Suspected or Known Coronary Artery Disease With Fewer High-Risk Test Results?
    George Beller · 2017 · Circulation Cardiovascular Imaging
96. Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis
    Meghna Joseph, Mrinal Murali Krishna, Chidubem G. Ezenna, Vinicius Pereira, Mahmoud Ismayl, Michael G. Nanna, Sripal Bangalore, Andrew Michael Goldsweig · 2024 · The American Journal of Cardiology
97. Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus
    Doron Aronson, Elazer Reuven Edelman · 2012 · Current Opinion in Pharmacology
98. In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken?
    David Joel Maron, Henry H. Ting · 2013 · Circulation Cardiovascular Interventions
99. Impact of coronary revascularization on the clinical and scintigraphic outlook of patients with myocardial ischemia
    Francesco Nudi, Enrica Procaccini, Francesco Versaci, Alessandro Giordano, Annamaria Pinto, Giandomenico Neri, Giacomo Frati, Orazio Schillaci, Alessandro Nudi, Fabrizio Tomai et al. · 2017 · Journal of Cardiovascular Medicine
100. The Current State of Coronary Revascularization: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
     Matthew A. Brown, Seth M. Klusewitz, John Alex Elefteriades, Lindsey M. Prescher · 2021 · International Journal of Angiology